Literature DB >> 18804145

Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice.

Kazuma Kaneko1, Akiyo Hineno, Kunihiro Yoshida, Shu-ichi Ikeda.   

Abstract

Ceruloplasmin (Cp) is the strongest ferroxidase in human plasma. Hereditary deficiency of this protein, named aceruloplasminemia, is an interesting model to elucidate the pathogenesis and pathophysiology of neurodegeneration induced by oxidative stress. Enhanced oxidative stress due to excessive iron accumulation is observed in the brains of aceruloplasminemia patients. Rotenone, a selective mitochondrial complex I inhibitor, induces neurodegeneration mimicking Parkinson's disease. We investigated the influence of Cp deficiency upon neurodegeneration using rotenone-treated, Cp-deficient mouse brains. Immunohistochemical examination showed that acrolein, one of the products of lipid peroxides, and ubiquitin were more markedly immunoreacted in the brains of rotenone-treated, Cp-deficient mice than in rotenone-untreated, Cp-deficient or rotenone-treated, wild-type mice. These molecules were localized in neuronal cells. These results suggested that rotenone-induced lipid peroxidation and accumulation of ubiquitin immunoreactivity were enhanced in the absence of Cp. Therefore, Cp may protect neuronal cells from oxidative stress-induced neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804145     DOI: 10.1016/j.neulet.2008.08.089

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Adaptation and sensitization to proteotoxic stress.

Authors:  Rehana K Leak
Journal:  Dose Response       Date:  2013-08-05       Impact factor: 2.658

2.  Brain Ceruloplasmin Expression After Experimental Intracerebral Hemorrhage and Protection Against Iron-Induced Brain Injury.

Authors:  Hongwei Liu; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2018-10-12       Impact factor: 6.829

3.  Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats.

Authors:  Jun Wang; Mingxia Bi; Junxia Xie
Journal:  Cell Mol Neurobiol       Date:  2015-02-06       Impact factor: 5.046

4.  Ceruloplasmin Deficiency Impaired Brain Iron Metabolism and Behavior in Mice.

Authors:  Lijing Niu; Yi Zhou; Li Lu; Aixia Su; Xiaoqiang Guo
Journal:  Cell Biochem Biophys       Date:  2022-02-11       Impact factor: 2.989

Review 5.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 6.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

7.  Physical activity is linked to ceruloplasmin in the striatum of intact but not MPTP-treated primates.

Authors:  Rehana K Leak; Krassimira A Garbett; Amanda M Dettmer; Zhiming Zhang; Károly Mirnics; Judy L Cameron
Journal:  Cell Tissue Res       Date:  2012-09-02       Impact factor: 5.249

8.  Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke.

Authors:  Sarah J Texel; Jian Zhang; Simonetta Camandola; Erica L Unger; Dennis D Taub; Raymond C Koehler; Z Leah Harris; Mark P Mattson
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

9.  Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity.

Authors:  Akiyo Hineno; Kazuma Kaneko; Kunihiro Yoshida; Shu-ichi Ikeda
Journal:  Neurochem Res       Date:  2011-06-26       Impact factor: 3.996

10.  Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivo.

Authors:  Jessica M Posimo; Amanda M Titler; Hailey J H Choi; Ajay S Unnithan; Rehana K Leak
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.